Chem Shift validation: AVS_full
BMRB Entry DOI: doi:10.13018/BMR51378
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Henot, Faustine; Crublet, Elodie; Frech, Matthias; Boisbouvier, Jerome. "NMR assignment of human HSP90 N-terminal domain bound to a long residence time resorcinol ligand" Biomol. NMR Assignments 16, 257-266 (2022).
PubMed: 35701717
Assembly members:
entity_1, polymer, 236 residues, Formula weight is not available
entity_6FJ, non-polymer, 424.382 Da.
Natural source: Common Name: Human Taxonomy ID: 9606 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Homo sapiens
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: pET-28
Data type | Count |
13C chemical shifts | 673 |
15N chemical shifts | 200 |
1H chemical shifts | 460 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | N-terminal domain of human HSP90 alpha form | 1 |
2 | long residence time resorcinol inhibitor | 2 |
Entity 1, N-terminal domain of human HSP90 alpha form 236 residues - Formula weight is not available
1 | PHE | GLU | ASN | LEU | TYR | PHE | GLN | GLY | ASP | GLN | ||||
2 | PRO | MET | GLU | GLU | GLU | GLU | VAL | GLU | THR | PHE | ||||
3 | ALA | PHE | GLN | ALA | GLU | ILE | ALA | GLN | LEU | MET | ||||
4 | SER | LEU | ILE | ILE | ASN | THR | PHE | TYR | SER | ASN | ||||
5 | LYS | GLU | ILE | PHE | LEU | ARG | GLU | LEU | ILE | SER | ||||
6 | ASN | SER | SER | ASP | ALA | LEU | ASP | LYS | ILE | ARG | ||||
7 | TYR | GLU | SER | LEU | THR | ASP | PRO | SER | LYS | LEU | ||||
8 | ASP | SER | GLY | LYS | GLU | LEU | HIS | ILE | ASN | LEU | ||||
9 | ILE | PRO | ASN | LYS | GLN | ASP | ARG | THR | LEU | THR | ||||
10 | ILE | VAL | ASP | THR | GLY | ILE | GLY | MET | THR | LYS | ||||
11 | ALA | ASP | LEU | ILE | ASN | ASN | LEU | GLY | THR | ILE | ||||
12 | ALA | LYS | SER | GLY | THR | LYS | ALA | PHE | MET | GLU | ||||
13 | ALA | LEU | GLN | ALA | GLY | ALA | ASP | ILE | SER | MET | ||||
14 | ILE | GLY | GLN | PHE | GLY | VAL | GLY | PHE | TYR | SER | ||||
15 | ALA | TYR | LEU | VAL | ALA | GLU | LYS | VAL | THR | VAL | ||||
16 | ILE | THR | LYS | HIS | ASN | ASP | ASP | GLU | GLN | TYR | ||||
17 | ALA | TRP | GLU | SER | SER | ALA | GLY | GLY | SER | PHE | ||||
18 | THR | VAL | ARG | THR | ASP | THR | GLY | GLU | PRO | MET | ||||
19 | GLY | ARG | GLY | THR | LYS | VAL | ILE | LEU | HIS | LEU | ||||
20 | LYS | GLU | ASP | GLN | THR | GLU | TYR | LEU | GLU | GLU | ||||
21 | ARG | ARG | ILE | LYS | GLU | ILE | VAL | LYS | LYS | HIS | ||||
22 | SER | GLN | PHE | ILE | GLY | TYR | PRO | ILE | THR | LEU | ||||
23 | PHE | VAL | GLU | LYS | GLU | ARG | ASP | LYS | GLU | VAL | ||||
24 | SER | ASP | ASP | GLU | ALA | GLU |
Entity 2, long residence time resorcinol inhibitor - C21 H17 F N4 O5 - 424.382 Da.
1 | 6FJ |
Download HSQC peak lists in one of the following formats:
CSV: Backbone
or all simulated peaks
SPARKY: Backbone
or all simulated peaks